235 related articles for article (PubMed ID: 35623497)
1. Tau R2 and R3 are essential regions for tau aggregation, seeding and propagation.
Annadurai N; Malina L; Malohlava J; Hajdúch M; Das V
Biochimie; 2022 Sep; 200():79-86. PubMed ID: 35623497
[TBL] [Abstract][Full Text] [Related]
2. Time- and dose-dependent seeding tendency of exogenous tau R2 and R3 aggregates in cells.
Annadurai N; Hrubý J; Kubíčková A; Malina L; Hajdúch M; Das V
Biochem Biophys Res Commun; 2023 Apr; 653():102-105. PubMed ID: 36863211
[TBL] [Abstract][Full Text] [Related]
3. Antitumour drugs targeting tau R3 VQIVYK and Cys322 prevent seeding of endogenous tau aggregates by exogenous seeds.
Annadurai N; Malina L; Salmona M; Diomede L; Bastone A; Cagnotto A; Romeo M; Šrejber M; Berka K; Otyepka M; Hajdúch M; Das V
FEBS J; 2022 Apr; 289(7):1929-1949. PubMed ID: 34743390
[TBL] [Abstract][Full Text] [Related]
4. Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau.
Jackson SJ; Kerridge C; Cooper J; Cavallini A; Falcon B; Cella CV; Landi A; Szekeres PG; Murray TK; Ahmed Z; Goedert M; Hutton M; O'Neill MJ; Bose S
J Neurosci; 2016 Jan; 36(3):762-72. PubMed ID: 26791207
[TBL] [Abstract][Full Text] [Related]
5. Conformation determines the seeding potencies of native and recombinant Tau aggregates.
Falcon B; Cavallini A; Angers R; Glover S; Murray TK; Barnham L; Jackson S; O'Neill MJ; Isaacs AM; Hutton ML; Szekeres PG; Goedert M; Bose S
J Biol Chem; 2015 Jan; 290(2):1049-65. PubMed ID: 25406315
[TBL] [Abstract][Full Text] [Related]
6. Tau P301L mutation promotes core 4R tauopathy fibril fold through near-surface water structuring and conformational rearrangement.
Vigers MP; Lobo S; Najafi S; Dubose A; Tsay K; Ganguly P; Longhini AP; Jin Y; Buratto SK; Kosik KS; Shell MS; Shea JE; Han S
bioRxiv; 2023 Nov; ():. PubMed ID: 38077065
[TBL] [Abstract][Full Text] [Related]
7. Precision proteoform design for 4R tau isoform selective templated aggregation.
Longhini AP; DuBose A; Lobo S; Vijayan V; Bai Y; Rivera EK; Sala-Jarque J; Nikitina A; Carrettiero DC; Unger MT; Sclafani OR; Fu V; Beckett ER; Vigers M; Buée L; Landrieu I; Shell S; Shea JE; Han S; Kosik KS
Proc Natl Acad Sci U S A; 2024 Apr; 121(15):e2320456121. PubMed ID: 38568974
[TBL] [Abstract][Full Text] [Related]
8. Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.
Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; Ghetti B; DeTure MA; Dickson DW; Vinters HV; Eisenberg DS
J Biol Chem; 2019 Nov; 294(44):16451-16464. PubMed ID: 31537646
[TBL] [Abstract][Full Text] [Related]
9. Inert and seed-competent tau monomers suggest structural origins of aggregation.
Mirbaha H; Chen D; Morazova OA; Ruff KM; Sharma AM; Liu X; Goodarzi M; Pappu RV; Colby DW; Mirzaei H; Joachimiak LA; Diamond MI
Elife; 2018 Jul; 7():. PubMed ID: 29988016
[TBL] [Abstract][Full Text] [Related]
10. Zn
Li X; Du X; Ni J
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678122
[TBL] [Abstract][Full Text] [Related]
11. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
[TBL] [Abstract][Full Text] [Related]
12. Site-specific amino acid D-isomerization of Tau R2 and R3 peptides changes the fibril morphology, resulting in attenuation of Tau aggregation inhibitor potency.
Murata T; Ito G; Utsunomiya-Tate N
Biochem Biophys Res Commun; 2023 Apr; 654():18-25. PubMed ID: 36878036
[TBL] [Abstract][Full Text] [Related]
13. Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.
Weismiller HA; Murphy R; Wei G; Ma B; Nussinov R; Margittai M
J Biol Chem; 2018 Nov; 293(45):17336-17348. PubMed ID: 30242125
[TBL] [Abstract][Full Text] [Related]
14. Highly Specific and Sensitive Target Binding by the Humanized pS396-Tau Antibody hC10.2 Across a Wide Spectrum of Alzheimer's Disease and Primary Tauopathy Postmortem Brains.
Helboe L; Rosenqvist N; Volbracht C; Pedersen LØ; Pedersen JT; Christensen S; Egebjerg J; Christoffersen CT; Bang-Andersen B; Beach TG; Serrano GE; Falsig J
J Alzheimers Dis; 2022; 88(1):207-228. PubMed ID: 35570492
[TBL] [Abstract][Full Text] [Related]
15. Hydration and Dynamics of Full-Length Tau Amyloid Fibrils Investigated by Solid-State Nuclear Magnetic Resonance.
Dregni AJ; Duan P; Hong M
Biochemistry; 2020 Jun; 59(24):2237-2248. PubMed ID: 32453948
[TBL] [Abstract][Full Text] [Related]
16. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
Oakley DH; Klickstein N; Commins C; Chung M; Dujardin S; Bennett RE; Hyman BT; Frosch MP
J Neurosci; 2021 May; 41(19):4335-4348. PubMed ID: 33893219
[TBL] [Abstract][Full Text] [Related]
17. Tau assembly: the dominant role of PHF6 (VQIVYK) in microtubule binding region repeat R3.
Ganguly P; Do TD; Larini L; LaPointe NE; Sercel AJ; Shade MF; Feinstein SC; Bowers MT; Shea JE
J Phys Chem B; 2015 Apr; 119(13):4582-93. PubMed ID: 25775228
[TBL] [Abstract][Full Text] [Related]
18. Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.
Guo JL; Narasimhan S; Changolkar L; He Z; Stieber A; Zhang B; Gathagan RJ; Iba M; McBride JD; Trojanowski JQ; Lee VM
J Exp Med; 2016 Nov; 213(12):2635-2654. PubMed ID: 27810929
[TBL] [Abstract][Full Text] [Related]
19. Major Differences between the Self-Assembly and Seeding Behavior of Heparin-Induced and in Vitro Phosphorylated Tau and Their Modulation by Potential Inhibitors.
Despres C; Di J; Cantrelle FX; Li Z; Huvent I; Chambraud B; Zhao J; Chen J; Chen S; Lippens G; Zhang F; Linhardt R; Wang C; Klärner FG; Schrader T; Landrieu I; Bitan G; Smet-Nocca C
ACS Chem Biol; 2019 Jun; 14(6):1363-1379. PubMed ID: 31046227
[TBL] [Abstract][Full Text] [Related]
20. Direct Observation of the Self-Aggregation of R3R4 Bi-repeat of Tau Protein.
Jayan P; Vahid AA; Kizhakkeduth ST; Muhammed SOH; Shibina AB; Vijayan V
Chembiochem; 2021 Jun; 22(12):2093-2097. PubMed ID: 33826208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]